Skip to main content

A Randomized, Double-Blind, Placebo Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of ABBV-0805 in Patients with Parkinson's Disease

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Movement Disorders

Awarded By

AbbVie Inc.

Start Date

November 13, 2019

End Date

November 12, 2020
 

Administered By

Neurology, Movement Disorders

Awarded By

AbbVie Inc.

Start Date

November 13, 2019

End Date

November 12, 2020